Hey folks, Tim here.

The market continues to heat up in 2025!

There are profit opportunities all over the place.

One of my favorite stocks right now is Hims & Hers Health Inc. (NYSE: HIMS) …

I’m sure that you’ve heard of HIMS by now. It’s a personal care company that sells supplements, skin care treatments, treatments for hair loss, erectile dysfunction, etc.

In February 2024, the company announced it would add GLP-1 weight loss products to the list.

Our AI swing trading bot, Iris, alerted an entry after the news. That’s when the stock was trading around $12 …

Take a look at the chart below. Every candle represents one trading day:

HIMS chart multi-month, 1-day candles Source: StocksToTrade

Get the next AI swing trade alert!

And for the hottest stocks that I’m watching on Monday …

Click HERE For My Full Watchlist This Week

P.S.Trump just announced 25% import tariffs on China, Mexico, and Canada. Stay alert in the market! Don’t make a trade unless you see a perfect setup. And use Iris to build smart positions!

Stay steady,

Tim Bohen

SteadyTrade Team Lead Trainer

Recommended Membership Gift

ACCESS NOW:

Click below to activate exclusive content and daily market intel from our market pros.

Bohen’s Exclusive Market Analysis and Watchlist Videos

Click Here to Unsubscribe

(As an Amazon Associate, we earn from qualifying purchases.)

13809 Research Boulevard, Suite 500, Austin, TX 78750

*Please note that these kinds of trading results are not typical. Most traders lose money. It takes years of dedication, hard work, and discipline to learn how to trade, and individual results will vary. Trading is inherently risky. Before making any trades, remember to do your due diligence and never risk more than you can afford to lose.

This is for informational purposes only as StocksToTrade is not registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund.

StocksToTrade cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing.

StocksToTrade in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, StocksToTrade accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.